Back

Modifiable risk factors and 5-year and lifetime risks of cardiovascular disease among 0.5 million hypertensive patients in primary care

30 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in hypertension Lifestyle Modification ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jiangshui Wang

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

5 More presentations in this session

Presentation thumbnail
Baseline characteristics and antihypertensive patterns in Finnish patients with hypertension and kidney disease
Professor T. Niiranen (Turku, FI)
Abstract Slides Video
Presentation thumbnail
Artificial intelligence-assisted personalised dose titration for hypertension: safety and feasibility results of the CURATE.AI pilot randomised controlled trial
Doctor X. Tadeo (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Renal function and hyperkalemia with first-line eplerenone in obese patients with hypertension: randomized safety data from the HEBRO trial
Doctor P. Iliakis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Predicting individual blood pressure response to additional antihypertensive treatment: a prototype decision support tool for healthcare professionals in the community
Associate Professor A. Gupta (London, GB)
Abstract Slides Video
Presentation thumbnail
Digital AI lifestyle support improves blood pressure control on top of standard dual antihypertensive therapy
Mr B. Rozibaev (Tashkent, UZ)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in hypertension

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparative impact of cardiometabolic multimorbidity clusters and distinct obesity indicators on cardiovascular disease in chinese middle-aged and older adult
29 August 2026
thumbnail
Congress Presentation
Featured Lecture: global effect of blood-pressure and lipid attainment on cardiovascular disease and mortality
25 April 2026
thumbnail
Congress Presentation
Predominant contribution of lifestyle versus metabolic risk factors to early-onset myocardial infarction (EOMI)
28 August 2026
thumbnail
Congress Presentation
Association of Life’s Essential 8 and its components with adverse cardiovascular and kidney events in patients with atherosclerotic cardiovascular disease: a prospective cohort study
31 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources